Claire Sathe
0000-0002-6707-603X
2 papers found
Refreshing results…
Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: MAINTAIN Trial
Social determinants of health and CDK4/6 inhibitor use and outcomes among patients with metastatic breast cancer
Missing publications? Search for publications with a matching author name.